Search Results 1301-1310 of 13800 for Assay
GRAIL is using deep sequencing of circulating cell-free nucleic acids (cfNAs) to develop assays to detect cancer early in blood. The purpose of this study ...
Positive for human leukocyte antigen (HLA) DSA (using single-antigen bead based assays) post-transplant. Local laboratory DSA results will be reviewed by ...
... assays prior to enrollment; For patients with unknown hepatitis C virus ribonucleic acid (HCV RNA) status, must be tested during study screening; patients ...
Serum free light chain (FLC) assay: Involved FLC level ≥ 10 mg/dl (≥ 100 mg/L) and an abnormal serum FLC ratio (< 0.26 or > 1.65). Subject has confirmed ...
This research study is being done to create a collection of biospecimens (blood, urine, cyst fluid, bile, kidney or liver tissue, etc.) ...
Estrogen receptor and PgR assays are considered positive if there are at least 1% positive tumor nuclei in the sample as defined in the relevant American ...
As a secondary (exploratory) objective, we seek to establish and validate novel biomarker assays to screen for TTR-CA using blood and urine samples ...
Search the more than 400 medical, surgical, health sciences, and biomedical research training programs at Mayo Clinic College of ...
Latent tuberculosis infection defined as positive interferon gamma release assay (IGRA), by QuantiFERON-TB Gold testing at Screening. History of clinically ...
... assay. Locally advanced or metastatic breast cancer with either measurable (according to RECIST 1.1 [Eisenhauer, et al, 2009]) or non-measurable lesions ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.